GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
1. Bleeker FE, Molenaar RJ, Leenstra S. (2012) Recent advances in the molecular understanding of glioblastoma. J Neurooncol, 108 (1): 11-27. [PMID:22270850]
2. Cohen AL, Holmen SL, Colman H. (2013) IDH1 and IDH2 mutations in gliomas. Curr Neurol Neurosci Rep, 13 (5): 345. [PMID:23532369]
3. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC et al.. (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature, 462 (7274): 739-44. [PMID:19935646]
4. Garber K. (2010) Oncometabolite? IDH1 discoveries raise possibility of new metabolism targets in brain cancers and leukemia. J Natl Cancer Inst, 102 (13): 926-8. [PMID:20576929]
5. Jin G, Reitman ZJ, Spasojevic I, Batinic-Haberle I, Yang J, Schmidt-Kittler O, Bigner DD, Yan H. (2011) 2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations. PLoS ONE, 6 (2): e16812. [PMID:21326614]
6. Molenaar RJ, Radivoyevitch T, Maciejewski JP, van Noorden CJ, Bleeker FE. (2014) The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation. Biochim Biophys Acta, 1846 (2): 326-41. [PMID:24880135]
7. Stein EM. (2016) Molecular Pathways: IDH2 Mutations-Co-opting Cellular Metabolism for Malignant Transformation. Clin Cancer Res, 22 (1): 16-9. [PMID:26553750]
8. Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, Cross JR, Fantin VR, Hedvat CV, Perl AE et al.. (2010) The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell, 17 (3): 225-34. [PMID:20171147]
To cite this family introduction, please use the following:
1.1.1.42 Isocitrate dehydrogenases, introduction. Last modified on 15/12/2015. Accessed on 02/07/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetoimmunopharmacology.org/GRAC/FamilyIntroductionForward?familyId=922.